Revvity | PKI - 销售成本



金融业
股票价格
USD
资产
USD 12B
现金及等价物
USD 860.32M
销售成本
USD 323.46M
流动资产
USD 2.13B
流动负债
USD 1.24B
债务
USD 3.4B
股息收益率
0.32
EBIT
USD 82.77M
EBITDA
USD 272.91M
员工
11K
EPS每股收益
USD 1.06
股本和储备
USD 7.25B
销售毛利
USD 387.66M
债务利息支出
USD 24.72M
利息收入
USD 5.75M
贷款资金
USD 2.63B
市值
USD 13.8B
净收入
USD 40.72M
营业费用
USD 628.35M
营业利润
USD 82.77M
普通股股本
USD 111.8M
PE价格收益
30.79
税前利润
USD 91.56M
销售收入
USD 711M
销售和管理费用
USD 253.88M
股票
USD 387.51M
贸易债权人
USD 169.68M
应收帐款人
USD 691.38M


销售成本 更改 日
Agilent USD 845M 7M 2026-03
Align Technology USD 303.5M 60.47M 2026-03
Bio Techne USD 103.13M 1.47M 2026-03
Bio-Rad Laboratories USD 348M 38.4M 2025-12
Bruker USD 443.6M 84.4M 2026-03
Celltrion KRW 92.83B 14.59B 2026-03
Charles River Laboratories USD 716.51M 5.76M 2026-03
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Danaher USD 2.36B 512M 2026-03
Dentsply International USD 453M 65M 2026-03
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 12.39B 1.76B 2026-03
Edwards Lifesciences USD 362.6M 19.6M 2026-03
Illumina USD 370M 30M 2026-03
Intuitive Surgical USD 931.9M 8.4M 2026-06
IQVIA Holdings USD 3.08B 161M 2026-03
Kangmei Pharma CNY 841.45M 271.27M 2026-03
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Laboratory Of America USD 2.6B 4.2M 2026-03
Medical Developments International AUD 7.09M 4.91M 2025-12
Mesa Laboratories USD 21.92M 1.78M 2024-09
Mettler Toledo International USD 410.92M 63.05M 2026-03
Myriad Genetics USD 63M 1.1M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
OraSure Technologies USD 15.43M 113K 2025-12
Organigram Holdings CAD 43.39M 13.54M 2026-03
Pacific Biosciences Of California USD 28.9M 10M 2025-12
Pharma Mar EUR 3.66M 116K 2026-03
Qiagen NV USD 217.43M 29.65M 2025-12
Quest Diagnostics USD 1.99B 57M 2026-03
Quidel USD -79.5M 528.3M 2026-03
Repligen USD 85.97M 8.11M 2026-03
Revvity USD 323.46M 26.93M 2026-03
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Thermo Fisher Scientific USD 6.96B 620M 2026-03
Tilray USD 164.37M 8.41M 2025-09
Waters USD 725M 350.06M 2026-03
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03